CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
AOSEPT® Plus contact lens solution +4 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01594294
NCT01594294N/ACompleted

EVALUATION OF THE EFFECTS OF CLEAR CARE® / AOSEPT® PLUS HYDROGEN PEROXIDE SOLUTION ON THE EYELID TISSUES - Part III: COMPARATIVE EVALUATION WITH RENU® MPS OVER 3 MONTH OF WEAR - CONTROL EVALUATION WITH AIR OPTIX® AQUA and ACUVUE® 2®

Alcon Research·interventional·Posted May 9, 2012·Updated Jul 25, 2014

In Brief

A clinical study evaluating AOSEPT® Plus contact lens solution, ReNu MultiPlus® contact lens solution, and 3 other interventions for Myopia. Completed, enrolled 100 participants.

Detailed Summary

The purpose of this study was to assess and compare the effect of the repeated usage of 2 different care systems (one hydrogen peroxide based cleaning and disinfecting system and one PHMB containing multipurpose system) with ACUVUE® 2® and AIR OPTIX® AQUA contact lenses worn on a daily wear basis for a 3-month period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 9, 2012
Enrollment StartApr 1, 2012
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 14.1 years ago

Interventions

AOSEPT® Plus contact lens solutiondevice

Hydrogen peroxide-based cleaning and disinfection system

ReNu MultiPlus® contact lens solutiondevice

Polyaminopropyl biguanide (PHMB) preserved multipurpose solution

Etafilcon A contact lensesdevice

Hydrogel contact lenses worn on a daily wear basis for 14 days (Screening Phase) and 3 months (Investigational Phase). During the Investigational Phase, the contact lenses lenses were worn a minimum of six hours per day, 5 days per week, with a fresh pair dispensed every 2 weeks.

Lotrafilcon B contact lensesdevice

Silicone hydrogel contact lenses worn on a daily wear basis for 30 days (Screening Phase) and 3 months (Investigational Phase). During the Investigational Phase, the contact lenses lenses were worn a minimum of six hours per day, 5 days per week, with a fresh pair dispensed monthly.

COMPLETE® MPS Easy Rub® Formula contact lens solutiondevice

PHMB 0.0001% and poloxamer 0.05% multipurpose solution